Visit the NEW CoM Homepage |  University of Kentucky |  UK HealthCare |  Give to Medicine |  Diversity  
UK College of Medicine logo Link to the College of Medicine web site
  • ed2
  • rs1
  • cs5
  • ad1

Internal Medicine - Gastroenterology

Internal Medicine

Division of
Digestive Diseases
and Nutrition

CONTACT

Inflammatory Bowel Disease

Open Studies

Crohn's Disease

ANDANTE I
Deborah Flomenhoft, MD, PI
A double-blind, randomized, placebo-controlled, dose ranging study to evaluate the efficacy and safety of PF-04236921 in patients with Crohn's who are anti-TNF inadequate responders. Patients can roll to Andante II, an open label extension.

Ulcerative Colitis

MERIT-UC
Deborah Flomenhoft, MD, PI
A randomized, double-blind, prospective trial to evaluate the efficacy of Methotrexate in induction and maintenance of steroid free remission of UC.

TURANDOT I (A7181009)
Deborah Flomenhoft, MD, PI
A double-blind, double dummy, randomized, placebo-controlled, parallel, dose ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis. Patients can roll to Turandot II, an open label safety extension study.

If you are interested in one of our ongoing studies, please contact us:

  • Krystal - (859) 323-6423
  • Sarah - (859) 323-6423
  • Sylvia - (859) 323-1086